转归期儿童起病生长激素缺乏症患者胰高血糖素激发试验的生长激素反应:体重指数与病因的作用
该研究纳入180例儿童起病生长激素缺乏症(CO-GHD)转归期患者,中位年龄17.39岁,进行胰高血糖素激发试验(GST)。结果显示GST峰值生长激素与垂体功能障碍严重程度显著负相关(P < .001),与BMI标准差评分负相关(ρ = -0.46,P < .001),但按疾病组校正后BMI影响大幅减弱。结论认为GST对评估转归期CO-GHD有参考价值,生长激素反应主要受垂体功能障碍严重程度影响,校正病因后BMI作用甚微。
要点
- GST峰值GH随垂体功能障碍严重程度增加而降低。
- GST峰值GH与BMI SDS呈负相关,但校正病因后影响减弱。
- 病因分层后GH峰值主要反映下丘脑-垂体损伤程度。
核心结论
- GST可为转归期CO-GHD患者的生长激素缺乏评估提供有价值的信息。
- GH对GST的反应主要受垂体功能障碍严重程度影响,校正病因后BMI作用甚微。
研究设计与样本
- 研究纳入180例儿童起病生长激素缺乏症(CO-GHD)患者,中位年龄17.39岁,均接受胰高血糖素激发试验(GST)。
- 按垂体缺陷数目和磁共振成像结果分为孤立性GHD(n = 80)、器质性中度GHD(1-2个缺陷伴先天或获得性异常,n = 63)和器质性重度GHD(≥3个缺陷伴复杂中枢神经系统异常,n = 37)。
- 按年龄相应BMI标准将患者分为正常体重、超重或肥胖;儿童癌症幸存者(CCS)占队列42%。
主要发现
- GST峰值GH与垂体功能障碍严重程度呈显著负相关(P < .001)。
- GST峰值GH与BMI标准差评分呈负相关(ρ = -0.46,P < .001)。
- 按疾病组校正后,BMI对GST反应的影响大幅减弱。
- 按病因或CCS状态分层后,GH峰值主要受下丘脑-垂体损伤影响,BMI作用甚微。
临床怎么用
- 转归期CO-GHD患者采用GST评估时,应结合垂体功能障碍严重程度和病因解读GH峰值。
- BMI对GST结果的影响在考虑病因后较小,解读时无需过度校正体重因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The glucagon stimulation test (GST) is increasingly used as an alternative to the insulin tolerance test for diagnosing persistent GH deficiency (GHD) during transition, though its accuracy and appropriate cutoff values are still uncertain. OBJECTIVE: To investigate the GH response to GST in transitional-age patients with childhood-onset GHD (CO-GHD), with a focus on the influence of body mass index (BMI) and the underlying etiology. PATIENTS AND METHODS: A total of 180 patients with CO-GHD (median age 17.39 years) underwent GST. They were grouped based on the number of pituitary deficiencies and magnetic resonance imaging findings into isolated GHD (n = 80), organic moderate GHD (1-2 deficiencies with congenital or acquired anomalies, n = 63), and organic severe GHD (≥3 deficiencies with complex central nervous system abnormalities, n = 37). Additionally, patients were classified by BMI as normal weight, overweight, or obesity, according to age-appropriate BMI criteria. Childhood cancer survivors (CCS) accounted for 42% of the cohort. RESULTS: Peak GH response to GST showed a significant inverse association with the severity of pituitary dysfunction (P < .001) and an inverse correlation with BMI SD score (ρ = -0.46, P < .001). However, adjusting by disease group strongly reduced the impact of BMI on the GST response. When stratified by etiology or CCS status, GH peaks were primarily influenced by hypothalamic-pituitary damage with BMI showing a minimal effect. CONCLUSION: The GST provides valuable insights into GH deficiency in transitional-age patients with CO-GHD. GH response is primarily influenced by the severity of pituitary dysfunction, with BMI playing a minimal role once adjusted for etiology.
引用
- Fava D, Parodi S, Angelelli A, et al. GH Response to Glucagon in Transition: Role of Body Mass Index and Etiology in Childhood-onset GH Deficiency. J Clin Endocrinol Metab. 2026. PMID: 41521526. doi:10.1210/clinem/dgaf674
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。